查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602392

激活素 A 市場：按類型、按應用分類 - 2025-2030 年全球預測

Activin-A Market by Type (Activin A Human, Activin A Mouse/ Rat), Application (Academic Research, Commercial Research) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年Activin A市值為2.628億美元，預計到2024年將達到2.8773億美元，複合年成長率為9.57%，到2030年將達到4.9854億美元。

激活素A是TGF-BETA超家族的成員，已知在調節發炎、細胞增殖、凋亡和組織修復等多種生理過程中發揮關鍵作用，是製藥和生物技術領域的重要藥物。市場範圍涵蓋纖維化疾病、癌症、生殖醫學和骨骼疾病等治療應用的需求。激活素 A 主要用於醫學研究和臨床試驗，作為研究分子途徑的實驗藥物，為學術界、製藥公司和生物技術公司的最終應用提供了廣闊的前景。激活素 A 市場的成長主要受到生物醫學研究的增加、對標靶治療的興趣日益成長以及對病理學狀況的不斷了解的影響。最新的機會在於基因治療和個人化醫療的進步，激活素 A 有潛力用於開發新的治療方法，特別是在罕見疾病和慢性發炎疾病方面。公司可以透過參與合作研究、投資醫藥應用研發以及與學術機構合作來抓住這些機會，以保持在這一領域的突破。然而，嚴格的監管通訊協定、高昂的研發成本以及醫療保健專業人員對潛在應用的認知較低等挑戰可能會阻礙市場成長。目前的市場已經成熟，適合非侵入性診斷工具的創新以及可最佳化激活素 A 治療效用的生物相似藥的開拓。與激活素 A 路徑相關的生物標記的鑑定開闢了新的研究和應用途徑，有可能解決疾病診斷和轉化醫學中未滿足的需求。總體而言，Activin A 市場尚處於起步階段，但充滿活力，需要創新和策略夥伴關係，以在潛在的監管和成本障礙中抓住新機會。

主要市場統計
基準年[2023] 2.628 億美元
預測年份 [2024] 2.8773 億美元
預測年份 [2030] 4.9854 億美元
複合年成長率（%） 9.57%

市場動態：揭示快速發展的激活素 A 市場的關鍵市場洞察

供給和需求的動態交互作用正在改變激活素 A 市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 細胞療法的需求不斷成長
    • 激活素 A 的益處，包括中胚層誘導、神經元分化、骨重塑和造血
  • 市場限制因素
    • 製造高成本
  • 市場機會
    • 廣泛的子適應症和可用的藥物標靶
    • 製造程序不斷進步
  • 市場挑戰
    • 攝取激活素 A 可能產生的副作用

波特五力：駕馭激活素 A 市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解激活素 A 市場的外部影響

外部宏觀環境因素在塑造激活素 A 市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解 Activin A 市場的競爭狀況

對 Activin A 市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣激活素 A 市場供應商的績效評估

FPNV定位矩陣是評估Activin A市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了激活素 A 市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對 Activin A 市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 細胞療法的需求不斷成長
      • 激活素 A 帶來的益處包括中胚層誘導、神經元分化、骨重塑和造血。
    • 抑制因素
      • 製造過程成本高
    • 機會
      • 廣泛的適應症和可用的藥物標靶
      • 生產流程的進步
    • 任務
      • 攝取激活素 A 可能產生的副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第 6 章 激活素 A 市場：按類型

  • 人類激活素A
  • 激活素A小鼠/大鼠

第 7 章 激活素 A 市場：依應用分類

  • 學術研究
  • 商業調查

第8章 Activin A 美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區Activin A市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲Activin A市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Ajinomoto Co., Inc.
  • Ansh Labs, LLC
  • Bio-Techne Corporation
  • BioLegend, Inc.
  • Cell Guidance Systems LLC
  • CellGenix GmbH
  • Enzo Life Sciences, Inc.
  • Merck KGaA
  • Miltenyi Biotec, Inc.
  • PeproTech, Inc.
  • Proteintech Group Inc.
  • Qkine Ltd.
  • RayBiotech, Inc.
  • STEMCELL Technologies Inc.
  • StemRD Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-035DA3C6369C

The Activin-A Market was valued at USD 262.80 million in 2023, expected to reach USD 287.73 million in 2024, and is projected to grow at a CAGR of 9.57%, to USD 498.54 million by 2030.

Activin-A is a member of the TGF-beta superfamily, known for its pivotal role in regulating various physiological processes, including inflammation, cell growth, apoptosis, and tissue repair, making it a significant focus in pharmaceuticals and biotechnology sectors. The market scope encompasses its necessity in therapeutic applications, particularly in fibrotic diseases, cancer, reproductive health, and bone disorders. Predominantly utilized in medical research and clinical trials, Activin-A serves as an experimental agent for studying molecular pathways, thereby offering substantial end-use prospects in academia, pharmaceutical companies, and biotechnology firms. Growth in the Activin-A market is primarily influenced by increasing biomedical research, growing interest in targeted therapies, and an expanding understanding of pathophysiological conditions. The latest opportunities lie in advancing gene therapy and personalized medicine, where Activin-A could be leveraged to develop novel treatments, particularly in rare diseases and chronic inflammatory conditions. Companies can seize these opportunities by engaging in collaborative research, investing in R&D for pharmaceutical applications, and forging alliances with academic institutions to stay abreast of breakthroughs in this niche. However, challenges such as stringent regulatory protocols, high costs of R&D, and limited awareness among healthcare professionals regarding its potential applications may hinder market growth. The current market is ripe for innovation in non-invasive diagnostic tools and the development of biosimilars that can optimize the therapeutic utility of Activin-A. Identifying biomarkers associated with Activin-A pathways could open new avenues for research and application, addressing unmet needs in disease diagnostics and translational medicine. Overall, the market for Activin-A remains nascent yet dynamic, necessitating continuous investment in innovation and strategic partnerships to leverage emerging opportunities amidst potential regulatory and cost barriers.

KEY MARKET STATISTICS
Base Year [2023] USD 262.80 million
Estimated Year [2024] USD 287.73 million
Forecast Year [2030] USD 498.54 million
CAGR (%) 9.57%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Activin-A Market

The Activin-A Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for cell therapy
    • Benefits provided by activin A such as mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis
  • Market Restraints
    • High cost of manufacturing process
  • Market Opportunities
    • Broad range of sub-indications and available drug targets
    • Increasing advancements in the production process
  • Market Challenges
    • Probable side effects due to consumption of activin A

Porter's Five Forces: A Strategic Tool for Navigating the Activin-A Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Activin-A Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Activin-A Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Activin-A Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Activin-A Market

A detailed market share analysis in the Activin-A Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Activin-A Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Activin-A Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Activin-A Market

A strategic analysis of the Activin-A Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Activin-A Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Ansh Labs, LLC, Bio-Techne Corporation, BioLegend, Inc., Cell Guidance Systems LLC, CellGenix GmbH, Enzo Life Sciences, Inc., Merck KGaA, Miltenyi Biotec, Inc., PeproTech, Inc., Proteintech Group Inc., Qkine Ltd., RayBiotech, Inc., STEMCELL Technologies Inc., StemRD Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Activin-A Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Activin A Human and Activin A Mouse/ Rat.
  • Based on Application, market is studied across Academic Research and Commercial Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for cell therapy
      • 5.1.1.2. Benefits provided by activin A such as mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of manufacturing process
    • 5.1.3. Opportunities
      • 5.1.3.1. Broad range of sub-indications and available drug targets
      • 5.1.3.2. Increasing advancements in the production process
    • 5.1.4. Challenges
      • 5.1.4.1. Probable side effects due to consumption of activin A
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Activin-A Market, by Type

  • 6.1. Introduction
  • 6.2. Activin A Human
  • 6.3. Activin A Mouse/ Rat

7. Activin-A Market, by Application

  • 7.1. Introduction
  • 7.2. Academic Research
  • 7.3. Commercial Research

8. Americas Activin-A Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Activin-A Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Activin-A Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ajinomoto Co., Inc.
  • 2. Ansh Labs, LLC
  • 3. Bio-Techne Corporation
  • 4. BioLegend, Inc.
  • 5. Cell Guidance Systems LLC
  • 6. CellGenix GmbH
  • 7. Enzo Life Sciences, Inc.
  • 8. Merck KGaA
  • 9. Miltenyi Biotec, Inc.
  • 10. PeproTech, Inc.
  • 11. Proteintech Group Inc.
  • 12. Qkine Ltd.
  • 13. RayBiotech, Inc.
  • 14. STEMCELL Technologies Inc.
  • 15. StemRD Inc.
  • 16. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. ACTIVIN-A MARKET RESEARCH PROCESS
  • FIGURE 2. ACTIVIN-A MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACTIVIN-A MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACTIVIN-A MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACTIVIN-A MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACTIVIN-A MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ACTIVIN-A MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ACTIVIN-A MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACTIVIN-A MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACTIVIN-A MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACTIVIN-A MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACTIVIN-A MARKET DYNAMICS
  • TABLE 7. GLOBAL ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACTIVIN-A MARKET SIZE, BY ACTIVIN A HUMAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACTIVIN-A MARKET SIZE, BY ACTIVIN A MOUSE/ RAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACTIVIN-A MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACTIVIN-A MARKET SIZE, BY COMMERCIAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ACTIVIN-A MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. ACTIVIN-A MARKET, FPNV POSITIONING MATRIX, 2023